Ray Roldan

6505-- Denosumab Injections

The Department of Veterans Affairs (VA) National Acquisition Center plans to release a Request for Proposal (RFP) for the procurement of Denosumab Injection, intended to serve multiple federal healthcare entities including the VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. This unrestricted procurement aims to award a single contract to a responsible offeror capable of providing a continuous supply of Denosumab, covering two dosage strengths: 60 mg and 120 mg injections, with estimated annual usage of approximately 22,737 and 5,472 units respectively. The contract will have a one-year base period and four additional one-year option periods, with distribution managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation will be issued electronically in compliance with FAR Part 12, with a release date around April 17, 2026, and a response deadline of May 5, 2026. Offerors must submit products under the exact drug name as labeled, with a unique National Drug Code (NDC), and are prohibited from relabeling products with other manufacturers' labels. All proposed covered drugs must comply with specific federal pricing requirements, including established Federal Ceiling Prices (FCPs) in line with 38 U.S.C. § 8126, and be included on the offeror’s Federal Supply Schedule contracts. Biosimilar products must be FDA-licensed and meet biosimilar criteria as outlined by federal law. If offering both vial and syringe presentations for the same strength, the contractor must propose the same price for both formats, and any alternate presentations introduced after contract award will be added at the contract price. Interested entities are encouraged to monitor SAM.gov for solicitation documents and updates.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Apr 22, 2026

36E79726R0018

Closed

Awarded3

6505--Metoprolol Tartrate IR Tablets Effective 5/8/2026 - 5/7/2027

The contract involves the procurement of Metoprolol Tartrate Tablets for the Department of Veterans Affairs, with the solicitation issued under number 36E79725R0071. The procurement aims to supply various dosages and packaging configurations of the medication, with a contract duration of one year and four additional one-year options. The solicitation, issued electronically, initially set the offer due date for November 18, 2025, but an amendment has extended this deadline to November 21, 2025, at 2:30 PM Central Time. The contract is targeted at responsible offerors capable of providing the specified drug in compliance with detailed requirements, including the inclusion of a 0.5% Cost Recovery Fee and unique National Drug Code (NDC) numbers for each drug offering. The procurement follows FAR Part 12 commercial item procedures and NAICS code 325412, with estimated annual usage quantities outlined for different strengths and package sizes. The point of contact for this solicitation is Contract Specialist Ray Roldan, based in Hines, Illinois. The overall goal is to establish a reliable supply chain for this essential medication across multiple federal healthcare agencies, ensuring continuity of care for veterans and other federal patients.

Department Of Veterans AffairsIL, USA$14M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0071

Awarded

Federal3

6505--Carbidopa Levodopa Immediate Release (IR) Tablets

The Department of Veterans Affairs (VA) National Acquisition Center plans to issue Request for Proposal (RFP) number 36E79726R0008 for the procurement of Carbidopa Levodopa Immediate Release (IR) Tablets. This acquisition is unrestricted and will support multiple federal health agencies including VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and Federal Health Care Centers (FHCC). The contract will cover a one-year base period with four additional one-year option periods, aiming to ensure a continuous and reliable supply of the medication. Distribution will be managed through the VA and DoD Pharmaceutical Prime Vendor Programs. The solicitation, adhering to commercial item acquisition procedures under FAR Part 12, will be released electronically on or about December 18, 2025, with proposals due by January 8, 2026. Offerors must submit electronically via SAM.gov, as no paper copies or telephone requests for solicitation documents are permitted. The procurement encompasses multiple dosage strengths and packaging configurations of Carbidopa Levodopa IR Tablets, including 10 mg/100 mg, 25 mg/100 mg, and 25 mg/250 mg combinations in bottles containing 100, 500, or 1,000 tablets. Estimated annual requirements exceed 300,000 bottles across these formulations and packaging options, with key stipulations that each drug product be supplied under the exact labeled name with a unique National Drug Code (NDC) associated solely with the successful contractor. Over-labeling of existing manufacturer labels is explicitly prohibited. The contract will be awarded to a single responsible offeror capable of maintaining an uninterrupted supply chain. Labeling, packaging, and inspection will comply with FDA requirements but no additional military packaging standards or specialized preservation criteria are mandated. Administrative oversight is based out of the VA National Acquisition Center in Hines, Illinois, with Ray Roldan serving as the primary contracting specialist contact. The solicitation includes mutually exclusive line items for equivalent packaging options, though pricing information is not provided in this presolicitation notice and will be submitted by offerors during the proposal phase. All communications, amendments, and documentation will be handled electronically via SAM.gov, ensuring transparency and accessibility throughout the procurement process.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Jan 22, 2026

unrestricted36E79726R0008

Closed

Awarded1

6505--Clobetasol Cream and Ointment Encube Ethicals, Inc. Base Ordering Period 11/17/2025 - 11/16/2026

This contract pertains to the procurement of Clobetasol Cream and Ointment, identified by the solicitation number 36E79725R0040, issued by Nac Pharmaceuticals, an organization based in Hines, Illinois. The contract was posted on May 22, 2025, with a response deadline set for June 10, 2025. The NAICS code associated with this procurement is 325412, indicating it falls within the pharmaceutical manufacturing sector. The contract is managed by a designated Contract Specialist, Ray Roldan, whose contact information is provided for inquiries. The procurement is intended to support the needs of the VA, with the opportunity details accessible via the provided link on SAM.gov. The specific scope of work, contract size, and place of performance details are not explicitly outlined in the available data.

Department Of Veterans AffairsIL, USA$6.3M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0040

Awarded Sep 16, 2025

Federal2

6505--Aripiprazole Tablets

The solicitation titled "6505--Aripiprazole Tablets" is issued by the Department of Veterans Affairs, specifically the NAC Pharmaceuticals division, for the procurement of Aripiprazole Tablets. The solicitation number is 36E79725R0052 and it is currently active, with details and future modifications accessible via the provided SAM.gov link. This opportunity falls under NAICS code 325412, which covers pharmaceutical preparation manufacturing, and is classified with code 6505. An amendment to this contract has extended the due date and time for the receipt of offers. The new response deadline for interested parties is July 28, 2025, at 14:30 CST. Ray Roldan is listed as the contract specialist and primary point of contact for inquiries regarding this solicitation. The office handling the contract is located in Hines, Illinois (zip code 60141). No specific set-aside type is indicated, and further details, including amendment documentation, are accessible through the SAM.gov resources and links included in the contract data.

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Jul 21, 2025

36E79725R0052

Closed

Awarded1

6505--Diclofenac NA 1% Topical Gel Exelan Pharmaceuticals, Inc. Base Ordering Period 9/3/2025 - 9/2/2026

The Department of Veterans Affairs, specifically through its NAC Pharmaceuticals division, has awarded a contract to Exelan Pharmaceuticals Inc. for the supply of Diclofenac NA 1% Topical Gel. The base ordering period for this contract runs from September 3, 2025, to September 2, 2026. The total contract value is $63,068,831.52, as detailed in award number 36E79725D0047. Exelan Pharmaceuticals, listed with a location in Boca Raton, FL, will be the supplier for this pharmaceutical product, which falls under NAICS code 325412 and classification code 6505. This award notice, posted on July 2, 2025, highlights the ongoing contractual relationship between the VA and its selected vendor for critical medication supply. The primary point of contact for the contract is Ray Roldan, a Contract Specialist, available via phone or email for further inquiries. The contracting office is based in Hines, Illinois. The contract represents a significant commitment to ensuring pharmaceutical needs are met for VA programs during the specified period, with additional resources and contract details accessible through the official SAM.gov listing.

Department Of Veterans AffairsIL, USA$63.1M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0012

Awarded Jul 2, 2025

Awarded1

6505--Lamotrigine Tablets Jubilant Cadista Pharmaceuticals, Inc. Base Ordering Period 6/16/2025 - 6/15/2026

This contract pertains to an amendment for the supply of Lamotrigine Immediate Release (IR) Tablets, identified under solicitation number 36E79725R0004. The contract is managed by Nac Pharmaceuticals, located in Hines, Illinois, and involves the procurement of pharmaceutical products for the VA or related federal agencies. The solicitation was posted on November 21, 2024, with a response deadline set for December 3, 2024, at 8:30 PM. The NAICS code associated with this contract is 325412, which covers pharmaceutical preparation manufacturing, indicating its focus on drug production and supply. The contract emphasizes the provision of Lamotrigine IR Tablets, a medication typically used for epilepsy and bipolar disorder, and is part of a broader effort to ensure the availability of essential medications for federal healthcare programs. The point of contact for inquiries is Contract Specialist Ray Roldan, whose contact details are provided for further communication. This contract is part of the federal procurement process, ensuring compliance with government standards and requirements for drug supply and distribution.

Department Of Veterans AffairsIL, USA$11.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79725R0004

Awarded Apr 16, 2025

Awarded1

6505--Lurasidone HCL Tablets Major Pharmaceuticals - 12/10/2024 - 12/9/2025

The Department of Veterans Affairs, specifically Nac Pharmaceuticals, has awarded contract 36E79725D0001 to The Harvard Drug Group, L.L.C. for the procurement of Lurasidone HCL Tablets. This award, associated with solicitation 36E79724R0022 and NAICS code 325412, is valued at 10,056,938.10 dollars. The contract was officially awarded on October 10, 2024, and covers a performance period starting December 10, 2024, and ending December 9, 2025. The contracting office is located in Hines, Illinois, with Ray Roldan serving as the designated Contract Specialist for this action.

Department Of Veterans AffairsIL, USA$10.1M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79724R0022

Awarded Oct 10, 2024

Federal1

6505--Dalfampridine SA Tablets (VA-25-00006887)

Department Of Veterans AffairsIL,

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

Posted Aug 12, 2024

36E79724Q0009

Closed

Awarded1

6505--BTK Inhibitors (Acalabrutinib Tablets 100 MG) Base Year Ordering Period - 6/24/24 - 3/23/25

This contract, issued by the Department of Veterans Affairs through Nac Pharmaceuticals, is an award to AstraZeneca Pharmaceuticals LP for the supply of BTK Inhibitors, specifically Acalabrutinib Tablets 100 MG. The agreement covers a base year ordering period from June 24, 2024, to March 23, 2025, with a total award value of 913,915,470.00 dollars. The awarded product serves as the sole agent on the VA National Formulary for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma indications for new patient starts. The procurement process involved a competitive evaluation of three potential BTK Inhibitors, including Ibrutinib, Acalabrutinib, and Zanubrutinib, based on a cost-per-day calculation for an estimated 2,444 patients across participating agencies. The contract structure includes a base year and four subsequent option years. The successful offeror is required to make all eligible package sizes available at a consistent price per tablet or capsule to ensure equitable pricing and supply across the VA healthcare system.

Department Of Veterans AffairsIL, USA$913.9M est.

NAICS

325412

Pharmaceutical Preparation Manufacturing

PSC

6505

Medical, Dental, and Veterinary Equipment and Supplies

36E79724R0007

Awarded Apr 24, 2024